Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression.

Rogers TJ, Christenson JL, Greene LI, O'Neill KI, Williams MM, Gordon MA, Nemkov T, D'Alessandro A, Degala GD, Shin J, Tan AC, Cittelly DM, Lambert JR, Richer JK.

Mol Cancer Res. 2018 Sep 13. doi: 10.1158/1541-7786.MCR-18-0246. [Epub ahead of print]

PMID:
30213797
2.

Gardening and age-related weight gain: Results from a cross-sectional survey of Denver residents.

Litt JS, Lambert JR, Glueck DH.

Prev Med Rep. 2017 Nov 2;8:221-225. doi: 10.1016/j.pmedr.2017.10.018. eCollection 2017 Dec.

3.

Lateral acetabular labral length is inversely related to acetabular coverage as measured by lateral center edge angle of Wiberg.

Petersen BD, Wolf B, Lambert JR, Clayton CW, Glueck DH, Jesse MK, Mei-Dan O.

J Hip Preserv Surg. 2016 Feb 29;3(3):190-6. doi: 10.1093/jhps/hnv084. eCollection 2016 Aug.

4.

Loss of the oncogenic phosphatase PRL-3 promotes a TNF-R1 feedback loop that mediates triple-negative breast cancer growth.

Gari HH, DeGala GD, Lucia MS, Lambert JR.

Oncogenesis. 2016 Aug 15;5(8):e255. doi: 10.1038/oncsis.2016.50.

5.

PRL-3 engages the focal adhesion pathway in triple-negative breast cancer cells to alter actin structure and substrate adhesion properties critical for cell migration and invasion.

Gari HH, DeGala GD, Ray R, Lucia MS, Lambert JR.

Cancer Lett. 2016 Oct 1;380(2):505-12. doi: 10.1016/j.canlet.2016.07.017. Epub 2016 Jul 21.

6.

Validation of neck axis distance as a radiographic measure for acetabular anteversion.

Nitschke A, Petersen B, Lambert JR, Glueck DH, Jesse MK, Strickland C, Mei-Dan O.

J Hip Preserv Surg. 2016 Jan 28;3(1):72-8. doi: 10.1093/jhps/hnv082. eCollection 2016 Apr.

7.

Genome-wide functional genetic screen with the anticancer agent AMPI-109 identifies PRL-3 as an oncogenic driver in triple-negative breast cancers.

Gari HH, Gearheart CM, Fosmire S, DeGala GD, Fan Z, Torkko KC, Edgerton SM, Lucia MS, Ray R, Thor AD, Porter CC, Lambert JR.

Oncotarget. 2016 Mar 29;7(13):15757-71. doi: 10.18632/oncotarget.7462.

8.

Dissecting Steroid Receptor Function by Analytical Ultracentrifugation.

Bain DL, De Angelis RW, Connaghan KD, Yang Q, Degala GD, Lambert JR.

Methods Enzymol. 2015;562:363-89. doi: 10.1016/bs.mie.2015.04.005. Epub 2015 Jun 12.

PMID:
26412661
9.

Glucocorticoid Receptor-DNA Dissociation Kinetics Measured in Vitro Reveal Exchange on the Second Time Scale.

De Angelis RW, Maluf NK, Yang Q, Lambert JR, Bain DL.

Biochemistry. 2015 Sep 1;54(34):5306-14. doi: 10.1021/acs.biochem.5b00693. Epub 2015 Aug 18.

PMID:
26267475
10.

Validation of a new radiographic measurement of acetabular version: the transverse axis distance (TAD).

Nitschke A, Lambert JR, Glueck DH, Jesse MK, Mei-Dan O, Strickland C, Petersen B.

Skeletal Radiol. 2015 Nov;44(11):1679-86. doi: 10.1007/s00256-015-2225-2. Epub 2015 Aug 4.

PMID:
26239191
11.

Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate.

Lambert JR, Whitson RJ, Iczkowski KA, La Rosa FG, Smith ML, Wilson RS, Smith EE, Torkko KC, Gari HH, Lucia MS.

Prostate. 2015 Feb 15;75(3):255-65. doi: 10.1002/pros.22911. Epub 2014 Oct 18.

12.

X chromosome inactivation analysis reveals a difference in the biology of ET patients with JAK2 and CALR mutations.

Allen C, Lambert JR, Linch DC, Gale RE.

Blood. 2014 Sep 25;124(13):2091-3. doi: 10.1182/blood-2014-06-580183. Epub 2014 Aug 19.

13.

The clinical utility of Multiplate analyser measurement in platelet function testing following stroke and transient ischaemic attack.

Mannu GS, Macartney A, Lambert JR, Bettencourt-Silva JH, Lawn M, Lyall H, Metcalf AK, Potter JF, Wood J, Clark A, Baglin T, Myint PK, Bowles KM.

Eur J Haematol. 2015 Feb;94(2):138-44. doi: 10.1111/ejh.12406. Epub 2014 Jul 24.

PMID:
24981148
14.

Steroid receptor-DNA interactions: toward a quantitative connection between energetics and transcriptional regulation.

Bain DL, Connaghan KD, Maluf NK, Yang Q, Miura MT, De Angelis RW, Degala GD, Lambert JR.

Nucleic Acids Res. 2014 Jan;42(2):691-700. doi: 10.1093/nar/gkt859. Epub 2013 Sep 24. Review.

15.

Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin.

Nordeen SK, Bona BJ, Jones DN, Lambert JR, Jackson TA.

Horm Cancer. 2013 Oct;4(5):293-300. doi: 10.1007/s12672-013-0150-1. Epub 2013 Jul 9.

16.

Analysis of a glucocorticoid-estrogen receptor chimera reveals that dimerization energetics are under ionic control.

Connaghan KD, Miura MT, Maluf NK, Lambert JR, Bain DL.

Biophys Chem. 2013 Feb;172:8-17. doi: 10.1016/j.bpc.2012.12.005. Epub 2012 Dec 26.

17.

Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2).

Whitson RJ, Lucia MS, Lambert JR.

J Cell Biochem. 2013 Jun;114(6):1424-33. doi: 10.1002/jcb.24484.

PMID:
23280549
18.

Glucocorticoid receptor-DNA interactions: binding energetics are the primary determinant of sequence-specific transcriptional activity.

Bain DL, Yang Q, Connaghan KD, Robblee JP, Miura MT, Degala GD, Lambert JR, Maluf NK.

J Mol Biol. 2012 Sep 7;422(1):18-32. doi: 10.1016/j.jmb.2012.06.005. Epub 2012 Jun 11.

19.

Effect of dietary vitamin D and calcium on the growth of androgen-insensitive human prostate tumor in a murine model.

Ray R, Banks M, Abuzahra H, Eddy VJ, Persons KS, Lucia MS, Lambert JR, Holick MF.

Anticancer Res. 2012 Mar;32(3):727-31.

20.

From steroid receptors to cytokines: the thermodynamics of self-associating systems.

Connaghan KD, Moody AD, Robblee JP, Lambert JR, Bain DL.

Biophys Chem. 2011 Nov;159(1):24-32. doi: 10.1016/j.bpc.2011.04.013. Epub 2011 Apr 27. Review.

21.

1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action.

Ray R, Lambert JR.

Bioorg Med Chem Lett. 2011 Apr 15;21(8):2537-40. doi: 10.1016/j.bmcl.2011.02.025. Epub 2011 Feb 18.

22.

A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.

Lambert JR, Eddy VJ, Young CD, Persons KS, Sarkar S, Kelly JA, Genova E, Lucia MS, Faller DV, Ray R.

Cancer Prev Res (Phila). 2010 Dec;3(12):1596-607. doi: 10.1158/1940-6207.CAPR-10-0122.

23.

HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.

Axlund SD, Lambert JR, Nordeen SK.

Mol Cancer Res. 2010 Dec;8(12):1643-55. doi: 10.1158/1541-7786.MCR-10-0111. Epub 2010 Nov 2.

24.

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma.

Lambert JR, Bomanji JB, Peggs KS, Thomson KJ, Chakraverty RK, Fielding AK, Kottaridis PD, Roughton M, Morris EC, Goldstone AH, Linch DC, Ell PJ, Mackinnon S.

Blood. 2010 Apr 8;115(14):2763-8. doi: 10.1182/blood-2009-11-255182. Epub 2010 Feb 2.

25.

In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm.

Lambert JR, Everington T, Linch DC, Gale RE.

Blood. 2009 Oct 1;114(14):3018-23. doi: 10.1182/blood-2009-03-209916. Epub 2009 Jun 18.

26.

The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia.

Lambert JR, Gale RE, Linch DC.

Br J Haematol. 2009 Apr;145(1):128-30. doi: 10.1111/j.1365-2141.2009.07597.x. Epub 2009 Jan 12.

PMID:
19222478
27.

p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms.

Kelly JA, Lucia MS, Lambert JR.

Cancer Lett. 2009 May 8;277(1):38-47. doi: 10.1016/j.canlet.2008.11.013. Epub 2008 Dec 18.

PMID:
19100681
28.

The JAK2 V617F mutation and thrombosis.

Austin SK, Lambert JR.

Br J Haematol. 2008 Nov;143(3):307-20. Review. Erratum in: Br J Haematol. 2008 Nov;143(3):451.

PMID:
19004076
29.

Growth factors in benign prostatic hyperplasia: basic science implications.

Lucia MS, Lambert JR.

Curr Urol Rep. 2008 Jul;9(4):272-8. Review.

PMID:
18765125
30.

Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease.

Desplats PA, Lambert JR, Thomas EA.

Neurobiol Dis. 2008 Sep;31(3):298-308. doi: 10.1016/j.nbd.2008.05.005. Epub 2008 May 22.

31.

Audit of the peri-delivery use of unfractionated heparin in women on therapeutic low-molecular weight heparin.

Lambert JR, Austin SK, Peebles D, Cohen H.

Br J Haematol. 2008 Jul;142(3):453-6. doi: 10.1111/j.1365-2141.2008.07198.x. Epub 2008 May 24.

PMID:
18510687
32.

The anticancer agent prodigiosin induces p21WAF1/CIP1 expression via transforming growth factor-beta receptor pathway.

Soto-Cerrato V, Viñals F, Lambert JR, Pérez-Tomás R.

Biochem Pharmacol. 2007 Nov 1;74(9):1340-9. Epub 2007 Jul 18.

PMID:
17765876
33.

Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cells.

Lambert JR, Young CD, Persons KS, Ray R.

Biochem Biophys Res Commun. 2007 Sep 14;361(1):189-95. Epub 2007 Jul 16.

PMID:
17658477
34.

Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor.

de Groot M, Teunissen MB, Ortonne JP, Lambert JR, Naeyaert JM, Picavet DI, Arreaza MG, Simon JS, Kraan M, Bos JD, de Rie MA.

Arch Dermatol Res. 2007 Sep;299(7):305-13. Epub 2007 Jul 24.

35.

Prodigiosin induces the proapoptotic gene NAG-1 via glycogen synthase kinase-3beta activity in human breast cancer cells.

Soto-Cerrato V, Viñals F, Lambert JR, Kelly JA, Pérez-Tomás R.

Mol Cancer Ther. 2007 Jan;6(1):362-9.

36.

Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells.

Appierto V, Villani MG, Cavadini E, Gariboldi M, De Cecco L, Pierotti MA, Lambert JR, Reid J, Tiberio P, Colombo N, Formelli F.

Oncogene. 2007 Jun 7;26(27):3952-62. Epub 2007 Jan 8.

PMID:
17213814
37.

Inhaled allergen-driven CD1c up-regulation and enhanced antigen uptake by activated human respiratory-tract dendritic cells in atopic asthma.

McCarthy NE, Jones HA, Marks NA, Shiner RJ, Ind PW, Al-Hassi HO, English NR, Murray CM, Lambert JR, Knight SC, Stagg AJ.

Clin Exp Allergy. 2007 Jan;37(1):72-82.

PMID:
17210044
38.

Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth.

Lambert JR, Kelly JA, Shim M, Huffer WE, Nordeen SK, Baek SJ, Eling TE, Lucia MS.

J Cell Physiol. 2006 Sep;208(3):566-74.

PMID:
16741990
39.

Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

Miller GJ, Miller HL, van Bokhoven A, Lambert JR, Werahera PN, Schirripa O, Lucia MS, Nordeen SK.

Cancer Res. 2003 Sep 15;63(18):5879-88.

40.

CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestins.

Lambert JR, Nordeen SK.

Mol Endocrinol. 2003 Jun;17(6):1085-94. Epub 2003 Mar 13.

PMID:
12637584
41.

Analysis of steroid hormone-induced histone acetylation by chromatin immunoprecipitation assay.

Lambert JR, Nordeen SK.

Methods Mol Biol. 2001;176:273-81. Review. No abstract available.

PMID:
11554328
42.

Use of a dry latex agglutination test to measure eradication of Helicobacter pylori infection.

Midolo PD, Dakic B, Nicholson L, Lambert JR, Lin S, Russell EG.

J Gastroenterol Hepatol. 2000 Mar;15(3):254-6.

PMID:
10764024
43.

In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori.

Midolo PD, Lambert JR, Kerr TG, Tee W.

Eur J Clin Microbiol Infect Dis. 1999 Nov;18(11):832-4. No abstract available.

PMID:
10614963
45.

Helicobacter pylori as a pathogenic factor in Ménétrier's disease.

Badov D, Lambert JR, Finlay M, Balazs ND.

Am J Gastroenterol. 1998 Oct;93(10):1976-9.

PMID:
9772069
46.

Diseases associated with Helicobacter pylori.

Dev AT, Lambert JR.

Med J Aust. 1998 Aug 17;169(4):220-5. Review. No abstract available.

PMID:
9734583
47.

An evaluation of whole blood testing for Helicobacter pylori in general practice.

Talley NJ, Lambert JR, Howell S, Xia HH, Lin SK, Agreus L.

Aliment Pharmacol Ther. 1998 Jul;12(7):641-5.

48.

The impact of Helicobacter pylori eradication on peptic ulcer healing.

Treiber G, Lambert JR.

Am J Gastroenterol. 1998 Jul;93(7):1080-4.

PMID:
9672334
49.

Oral treatment schedules for onychomycosis: a study of patient preference.

Nolting SK, Sanchez Carazo S, De Boulle K, Lambert JR.

Int J Dermatol. 1998 Jun;37(6):454-6.

PMID:
9646137
50.

Prevalence of Helicobacter pylori in a representative Anglo-Celtic population of urban Melbourne.

Lin SK, Lambert JR, Nicholson L, Lukito W, Wahlqvist M.

J Gastroenterol Hepatol. 1998 May;13(5):505-10.

PMID:
9641649

Supplemental Content

Loading ...
Support Center